Does TIRZEPATIDE Cause Product dose omission issue? 3,211 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 3,211 reports of Product dose omission issue have been filed in association with TIRZEPATIDE (Zepbound). This represents 3.2% of all adverse event reports for TIRZEPATIDE.
3,211
Reports of Product dose omission issue with TIRZEPATIDE
3.2%
of all TIRZEPATIDE reports
0
Deaths
47
Hospitalizations
How Dangerous Is Product dose omission issue From TIRZEPATIDE?
Of the 3,211 reports, 47 (1.5%) required hospitalization, and 4 (0.1%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TIRZEPATIDE. However, 3,211 reports have been filed with the FAERS database.
What Other Side Effects Does TIRZEPATIDE Cause?
Incorrect dose administered (23,301)
Injection site pain (10,989)
Nausea (10,018)
Off label use (7,007)
Extra dose administered (6,774)
Diarrhoea (5,463)
Vomiting (4,635)
Injection site haemorrhage (4,389)
Accidental underdose (3,897)
Injection site erythema (3,844)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which TIRZEPATIDE Alternatives Have Lower Product dose omission issue Risk?
TIRZEPATIDE vs TISAGENLECLEUCEL
TIRZEPATIDE vs TISLELIZUMAB
TIRZEPATIDE vs TISOTUMAB VEDOTIN
TIRZEPATIDE vs TISOTUMAB VEDOTIN-TFTV
TIRZEPATIDE vs TITANIUM DIOXIDE\ZINC